NCT04993040View on ClinicalTrials.gov

A PK Study of Oraxol in Breast Cancer Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 22, 2019

Primary Completion Date

December 9, 2019

Study Completion Date

December 9, 2020

Conditions
Breastcancer
Interventions
DRUG

Oraxol

"* HM30181 methanesulfonate monohydrate~* Oral paclitaxel capsules"

Trial Locations (1)

510000

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou

Sponsors

Lead Sponsor

Athenex, Inc.
All Listed Sponsors
lead

Athenex, Inc.

INDUSTRY